Navigation Links
Arkansas and Missouri Care Improvement Plus Members Overwhelmingly Pleased with Special Needs Plan
Date:11/12/2008

- First member satisfaction survey shows health improvements, disease

management support among valued benefits of plan -

ST. LOUIS, Nov. 12 /PRNewswire/ -- One year following the launch of operations in Arkansas and Missouri, 90 percent of members of Care Improvement Plus feel their health has maintained or improved, according to a recent survey examining the satisfaction of the plan's south central regional membership. Of those who feel health has improved, 96 percent cite Care Improvement Plus as contributing to their health improvement.

"This survey clearly demonstrates that members are pleased with Care Improvement Plus and the comprehensive approach to healthcare coverage that it provides," said Lee Spruiell, regional vice president of field operations for Care Improvement Plus. "The fact that 27 percent of members surveyed cite our plan as helping to improve their health after only one year of operations is encouraging and further supports the notion that special needs plans can provide enhanced quality and value to chronically ill Medicare beneficiaries."

The survey is the first to assess Care Improvement Plus plan member satisfaction since the plan underwent a major expansion in 2007, launching services in five additional states, including Arkansas and Missouri. Among the key findings from the survey:

-- Overall satisfaction was high: 93 percent of south central regional members were satisfied with the plan overall

-- Members are highly likely to recommend the plan to others: 89 percent of south central regional members were likely to recommend the plan to other Medicare beneficiaries with chronic illnesses

-- Members value plan benefits and coverage: More than 93 percent of south central regional members were completely or very satisfied with the plan's medical coverage and prescription drug benefits

-- Members are pleased with disease management support the plan provides: 93 percent of s
'/>"/>

SOURCE Care Improvement Plus
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Care Improvement Plus Launches 2009 Benefits in Arkansas
2. State, National Long Term Care Community Applauds Arkansas Leaders in U.S. Senate and U.S. House for Helping Lead Effort to Block $770 Million Bush Medicare Cuts
3. Alabama, Arkansas, Georgia, Mississippi, West Virginia, and Maryland Declare April 25th Parental Alienation Awareness Day
4. Farm Bill Provision Will Disrupt Arkansas Medicaid Program
5. Presidential Candidate and Former Arkansas Governor Mike Huckabee to Be Keynote Speaker for Hope International Universitys Celebrate Hope Dinner at Disneyland(R) Hotel
6. State of Arkansas Department of Human Services, Division of Medical Services Selects U.S. Care Management for High-Risk Obstetrics Health Management Program
7. RediClinic Adds Arkansas Blue Cross and Blue Shield Coverage in Fayetteville and Rogers
8. Schering-Plough to Appeal Jury Decision in Missouri Reimbursement Case
9. Care Improvement Plus Launches 2009 Benefits in Missouri
10. Missouri Firms New Ventilator Design Addresses Serious Homeland Security Issue
11. Racial disparities decline for cancer in Missouri

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., A team of Kendall Hunt ...er of the Year Award at the recent National Associ...e in St. Louis, November 5-7, 2009. , ...-- A team of Kendall Hunt authors earned the 2009 ...the recent National Association for Gifted Childre...
(Date:12/2/2009)..., , Ad in Today,s Washington Post ...ewswire-USNewswire/ -- If the Catholic bishops ...tative measures we take for granted may be under t...ght to bear on the debate over healthcare reform h...Washington Post warns of the likely impact if tha...
(Date:12/2/2009)... Insect repellents suspected in birth defect that ..., WEDNESDAY, Dec. 2 (HealthDay News) -- Male babie...rst three months of pregnancy appear to be at incr...researchers report. , This birth defect, which ...ves premature shortening of the urethra, the tube ...
(Date:12/2/2009)..., , Fruit flies may seem like unlikely heroes in ...ggests that these insects already used to study d...entists are reporting that fruit flies can be used... studying the effects of cocaine and other drugs o...n ACS Chemical Neuroscience , a new monthly journ...
(Date:12/2/2009)..., MyCareTeam, Inc., a lea...gement software, has released the newest version o...udes hypertension, congestive heart failure and we...isting diabetes monitoring features. , ...9 -- MyCareTeam, Inc., a leading vendor of Interne...
Breaking Medicine News(10 mins):Health News:Kendall Hunt Authors Earn NAGC “Paper of the Year” Award 2Health News:Everybody's Healthcare Is Threatened by Catholic Bishops' Interference 2Health News:MyCareTeam™ Significantly Extends Diabetes Offering to Include Management of Hypertension, Obesity, and Congestive Heart Failure 2
...our out of five hospitalized children receive medi...r adults//. The authors fear that treating childre...omes. "We measured the magnitude of off-labe...hiladelphia. "Given the nature of the available da...
...in Nigeria has been a success, but continued commi...icate the virus from northern states, say official...ive was launched in May 2006 by the National Progr...egions still affected by the virus. People i...
...ly diagnosis of lung cancer. They hope the analysi.../ lining the airways leading to the lungs can be u...s more effective. Lung cancer is the most dead...d and nearly 29,000 deaths. Part of the reas...
...sults of a study showing clearly that soft drinks ...gher body weight, a decrease in calcium and other ... The report also noted that studies funded b...le analyzed 88 previously published studies obtain...
...e accurate amount of fat in a human body, accordin... as the standard for measuring the amount of fat i...'s body weight divided by the square of their heig... at a greater risk of heart disease, diabetes and ...
...on educated in India, was Monday conferred with th... Ruit has conducted over 70,000 surgeries fo...indness in the subcontinent. "It is an apt a...d surgeon at the award ceremony here. Ruit h...
Other Medicine News:Health News:Prescribing Off Label Drugs for Children may Be Hazardous 2Health News:Prescribing Off Label Drugs for Children may Be Hazardous 3Health News:Nigerian Programme Increases Polio Immunisation 2Health News:Gene Cell Test may Aid Early Lung Cancer Diagnosis 2Health News:Yale Researchers Weigh the Science on Soft Drinks and Health 2
(Date:12/2/2009)...c. 2 Novartis announced today that...on Tasigna® (nilotinib) 200 mg capsules in a ...strength of the company,s hematology portfolio in ...a, at the 51st American Society of Hematology (ASH...pany,s current therapies and investigational agent...
(Date:12/1/2009)...wire/ -- Reportlinker.com announces that a new mar... ,, Medical Oxygen Systems - Global Market Op...0164334/Medical-Oxygen-Systems---Global-Market-Opp...stems market for home healthcare setting is reckon...wth expectations stem from demographic factors suc...
(Date:12/1/2009)...wire/ -- Reportlinker.com announces that a new mar... ,, Molecular Diagnostics - A World Market Rev...olecular-Diagnostics---A-World-Market-Review.html ...n by several growth factors that include the need ... combine optimized sample preparation, analysis, a...
Breaking Medicine Technology:Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 2Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 3Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 4Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 5Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 6Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 7Reportlinker Adds Molecular Diagnostics - A World Market Review 2Reportlinker Adds Molecular Diagnostics - A World Market Review 3Reportlinker Adds Molecular Diagnostics - A World Market Review 4Reportlinker Adds Molecular Diagnostics - A World Market Review 5Reportlinker Adds Molecular Diagnostics - A World Market Review 6OneDotOneLife org Saving the Lives of More Than 2 Million Children 5048 1OneDotOneLife org Saving the Lives of More Than 2 Million Children 5048 2Pres Clinton Announces Commitment From Inter American Development Bank Global Network for Neglected Tropical Diseases and Pan American Health Organ 5046 1Pres Clinton Announces Commitment From Inter American Development Bank Global Network for Neglected Tropical Diseases and Pan American Health Organ 5046 2Pres Clinton Announces Commitment From Inter American Development Bank Global Network for Neglected Tropical Diseases and Pan American Health Organ 5046 3Regence to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 5044 1Regence to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 5044 2Regence to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 5044 3
...J., Oct. 29 Sanofi-aventis,announced today that t...d,Apidra(R) (insulin glulisine [rDNA origin] injec...ears and older) with diabetes mellitus., The appr...FDA review of,a 26-week, phase III, open-label, ac... insulin lispro, in 572 children and adolescents (...
..., Oct. 29 CuraGen Corporation,(Nasdaq: CRGN ), a...on,oncology, announced today that Company executiv...t 11:00 a.m. ET on Monday, November 3, 2008,follow...sults and to review,preliminary data from CuraGen,...for the treatment of advanced melanoma., Data fro...
Other Medicine Technology:FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes 2FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes 3FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes 4FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes 5CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008 2
Shandon Pathcentre Tissue Processor
Shandon Excelsior Tissue Processor
Shandon Grosslab Junior Grossing Workstation
Shandon Hyperclean 2 Fume Handling Station
Medicine Products: